Skip Navigation
Skip to contents

KSC 2018

KSC 2018 : 대한심장학회 제62차 추계학술대회
10.11 Thu. - 13 Sat. / Grand Walkerhill Seoul, Korea

일정표 및 초록검색

Home > Program > 일정표 및 초록검색
  • Oral
  • CAD 3 163-170
  • Oct. 19 (Sat.) 10:20-11:50, Abstract/Case Zone 1 (Grand Hall)
  • Chairperson: 황흥곤
  • Panel: 유상용, 장재식
10:20-10:30
No: 163
[630107]

Impact of PCSK9 Levels on Long-Term Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention

[Speaker] 최익준
Ik Jun Choi, Dong Jae Lee, Won Jik Lee, Kwan Yong Lee, Mi-Jeong Kim, and Doo Soo Jeon  
The Catholic University of Korea, Incheon St. Mary`s Hospital

10:30-10:40
No: 164
[630566]

The safety and efficacy of Ecklonia cava Phlorotannin, PH100 in type 2 diabetes with recent cardiovascular complications: a multicenter, randomized, double-blind, placebo-controlled, and  phase IIa trial

[Speaker] 안효석
Hyo-Suk AHN1, Ki-Dong Yoo2, Eun-Joo Cho3, Hun-Jun Park4, Sung Yun Lee5, Tae-Ho Park6, Jang Young Kim7, Do?Sun Lim8, Soo-Joong Kim9, Ki-Chul Sung10, Hui-Kyung Jeon1
1Department of cardiology, Uijeongbu St. Mary`s Hospital. 2Department of cardiology, St. Vincent Hospital, 3Department of cardiology, Yeouido St Mary’s Hospital, 4Department of cardiology, Seoul St. Mary's Hospital, 5Department of cardiology, Inje University Ilsan Paik Hospital, 6Department of cardiology, Dong-A University Hospital, 7Department of cardiology, Wonju Severance Hospital, 8Department of cardiology, Korea University Anam Hospital, 9Department of cardiology, Kyung Hee University Hospital, 10Department of cardiology, Kangbuk Samsung Hospital

10:40-10:50
No: 165
[630327]

Cardiovascular Outcomes with Glucagon-like Peptide 1 Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes: A Meta-Analysis

[Speaker] 이영민
Yeong Min LEE1, Eun Ji PARK1, Young Ah PARK1, Han Young JIN1, Jeong Sook SEO1, Tae Hyun YANG1, Dae Kyung KIM1, Dong Soo KIM1, Jae Sik JANG1
1Department of Cardiology, Inje University College of Medicine Busan Paik Hospital, Busan, Korea

10:50-11:00
No: 166
[630462]

The effect of new P2Y12 inhibitor on all-cause death in AMI patients using Korean Registry of Regional Cardiocerebrovascular center for Acute Myocardial Infarction (KRAMI)

[Speaker] 이광민
Kwang-Min LEE, Moo-Hyun Kim, Kim Rock-Bum, Jin-Yong Hwang, Jang Hoon Lee
Dong-A University Medical Center, Gyeongsang National University Hospital, Kyungpook National University Hospital

11:00-11:10
No: 167
[630150]

Comparison Clinical Test between Microfluidic Platelet Function Assay(Anysis-200) and Turbidity-based Drug Response Assay(Verify-NOW)

[Speaker] 정영학
Young Hak Chung1, Minhee Cho1, Sehyun Shin2 and Byoung-Kwon Lee1
1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University college of Medicine, Seoul, Korea 2Department of Mechanical Engineering, Korea University, Seoul, Korea

11:10-11:20
No: 168
[630517]

Cilostazol Based Triple Versus Potent P2Y12 blockers based Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

[Speaker] 김우현
Woohyeun KIM1, Byoung Geol Choi2, Seung-Woon Rha1, Cheol Ung Choi1, Se Yeon Choi1, Jae Kyeong Byun1, Jinah Cha1, Dong Joo Oh3, Myung Ho Jeong4 and Other Korea Acute Myocardial Infarction Registry (KAMIR) investigators
1Korea University Guro Hospital, Seoul, Korea 2Institute of Health Science, Collage of Medicine, Korea University, Seoul, Korea 3Cardiovascular Intervention Research Institute, Seoul, South Korea 4Chonnam National University Hospital, Gwangju  

11:20-11:30
No: 169
[630370]

Differential effects of prolonged dual antiplatelet therapy after percutaneous coronary intervention in patients presenting with versus without acute myocardial infarction

[Speaker] 김지훈
Jihoon Kim1, Young Bin Song1, Ju-Hyeon Oh2, Deok-Kyu Cho3, Jin Bae Lee4, Joon-Hyung Doh5, Sang-Hyun Kim6, Jin-Ok Jeong7, Jang-Ho Bae8, Byung-Ok Kim9, Jang Hyun Cho10, Il-Woo Suh11, Doo-il Kim12, Hoon-Ki Park13, Jong-Seon Park14, Woong Gil Choi15, Wang Soo Lee16, Jihoon Kim1, Ki Hong Choi1, Taek Kyu Park1, Joo Myung Lee1, Jeong Hoon Yang1, Jin-Ho Choi1, Seung-Hyuk Choi1, Hyeon-Cheol Gwon1, Joo-Yong Hahn1, on behalf of the SMART-DATE investigators
1From the Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; 2Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; 3Myongji Hospital, Goyang, Korea; 4Daegu Catholic University Medical Center, Daegu, Korea; 5Inje University Ilsan Paik Hospital, Goyang, Korea; 6Seoul National University Boramae Medical Center, Seoul, Korea; 7Chungnam National University Hospital, Daejeon, Korea; 8Konyang University Hospital, Daejon, Korea; 9Inje University Sanggye Paik Hospital, Seoul, Korea; 10St. Carollo General Hospital, Suncheon, Korea; 11SAM medical center, Anyang, Korea; 12Inje University Haeundae Paik Hospital, Busan, Korea; 13Seoul Veterans Hospital, Seoul, Korea; 14Yeungnam University Hospital, Daegu, Korea; 15Chungju Konkuk University Medical Center, Chungju, Korea; 16Chung-Ang University Hospital, Seoul, Korea.

11:30-11:40
No: 170
[630578]

Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in hypertensive vasospastic angina patients

[Speaker] 국형돈
Hyungdon Kook1, Soon Jun Hong1, Sunki Lee2, Jung-Sun Kim3, Sang Yeob Lim4, Chang Gyu Park5
1Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea. 2Division of Cardiology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea. 3Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea. 4Division of Cardiology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea. 5Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.